Net Cash Provided by (Used in) Operating Activities |
30.7M |
USD |
-7.35% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
-53.4M |
USD |
+51.5% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
26.8M |
USD |
-10.3% |
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
200M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Shares, Issued |
31.6M |
shares |
-1.57% |
Q2 2024 |
Q2 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
4.18M |
USD |
|
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
141M |
USD |
+24.3% |
Q2 2024 |
Q2 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
34.4M |
USD |
+4.87% |
Q1 2024 |
Q1 2024 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
30.2M |
USD |
|
Q2 2024 |
Q2 2024 |
Deferred Income Tax Expense (Benefit) |
1.33M |
USD |
+492% |
Q1 2024 |
Q1 2024 |
Additional Paid in Capital |
709M |
USD |
-0.82% |
Q2 2024 |
Q2 2024 |
Depreciation, Depletion and Amortization |
164M |
USD |
-27.3% |
Q2 2024 |
Q2 2024 |
Share-based Payment Arrangement, Expense |
2.86M |
USD |
|
Q3 2022 |
Q3 2023 |
Interest Expense |
164M |
USD |
+3.24% |
Q2 2024 |
Q2 2024 |